Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
612.00
-18.00 (-2.86%)
At close: Apr 16, 2025
60.63%
Market Cap 98.30B
Revenue (ttm) 44.43M
Net Income (ttm) -588.83M
Shares Out 153.83M
EPS (ttm) -4.12
PE Ratio n/a
Forward PE 62.62
Dividend n/a
Ex-Dividend Date n/a
Volume 1,478,691
Average Volume 1,877,513
Open 625.00
Previous Close 630.00
Day's Range 610.00 - 634.00
52-Week Range 240.50 - 800.00
Beta 0.73
RSI 36.17
Earnings Date May 9, 2025

About TPE:6919

Caliway Biopharmaceuticals Co.Ltd develops small molecule drugs for medical aesthetic and inflammatory disease. The company was founded in 2012 and is based in New Taipei City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 6919
Full Company Profile

Financial Performance

In 2024, TPE:6919's revenue was 44.43 million, an increase of 14.13% compared to the previous year's 38.93 million. Losses were -588.83 million, 20.5% more than in 2023.

Financial Statements

News

There is no news available yet.